Please login to the form below

Not currently logged in

immune disease

This page shows the latest immune disease news and features for those working in and with pharma, biotech and healthcare.

Merck & Co to buy IO specialists Immune Design for $300m

Merck & Co to buy IO specialists Immune Design for $300m

US giant looks to next generation technology. Immunotherapy leader Merck &Co/MSD is to acquire a vaccine specialist firm Immune Design for $300m. ... Roger Perlmutter. “This acquisition builds upon Merck’s industry-leading programmes that harness the

Latest news

More from news
Approximately 1 fully matching, plus 46 partially matching documents found.

Latest Intelligence

  • Pharma deals in July 2015 Pharma deals in July 2015

    cCAM is developing an immune checkpoint protein belonging to the Human CEA (Carcino-Embryonic Antigen) protein family. ... Receptos / Celgene. Company acquisition. Ozanimod in Phase 3 for auto-immune disease.

  • Deal Watch table for May 2014 Deal Watch table for May 2014

    658. Avalanche / Regeneron. Development and commercialisation licence. Gene therapy products for ophthalmologic disease. ... MGD010, a preclinical bispecific antibody for treatment of auto-immune disease. 502.

  • Interview: AstraZeneca's Susan Galbraith Interview: AstraZeneca's Susan Galbraith

    Immuno-oncology. One area of interest for many pharma companies is the potential for immunotherapies - drugs that encourage the body's immune system to tackle a disease. ... or with other agents that might affect a different part of the immune system, or

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Australian Flu and the dilemma of naming diseases

    as disease carriers, and creating negative connections between the name and the country. ... Other examples include the damaging 1980s media branding of AIDS disease as GRID (gay-related immune deficiency) and the immense impact on local tourism for

  • Random42 Proud To Be Cannes Corporate Award Winners 2016

    Silver Winner - Random 42 for Systematic Lupus Erythematosus. This animation highlights the pathogenesis of Lupus, an autoimmune disease where the body’s own immune system attacks healthy tissue. This animation was

  • Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis

    market. PsA is an auto-immune disease which causes inflammation of the joints, pain and stiffness, which is accompanied by patches of red and white, scaly skin indicative of Psoriasis.PsA ... The exact causes of the disease are not yet known, but a

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company Conferences, Events and Exhibition Stands is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...